InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Insider track record
CFODisclosed buys
0
Disclosed sells
4
T+90 hit rate
100%
T+90 mean return
+10.8%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the detailed record of transactions filed by Daskal Ilan, Chief Financial Officer. Insider active across 4 companies, notably Natus Medical INC. Cumulatively, 19 disclosures have been logged. Split: 0 buy · 4 sells. Total volume traded: €486k. History available since 11 June 2021. The latest transaction was filed on 28 November 2024 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
Declarations19 total
39,783 shares0Common StockSEC:0001127602-24-028243:0
694 shares0Bio-Rad A Common StockSEC:0001062993-23-017644:0
700 shares0Bio-Rad A Common StockSEC:0001062993-23-009008:0
243 shares@ US$466.246.2% of flowBio-Rad A Common StockSEC:0001062993-23-009008:1
541 shares0Bio-Rad A Common StockSEC:0001062993-22-019274:0
455 shares0Bio-Rad A Common StockSEC:0001062993-22-019183:0
18,937 shares@ US$33.5063.0% of flowCommon Stock, $0.001 par value per shareSEC:0000878526-22-000092:0
5,075 shares0Common Stock, $0.001 par value per shareSEC:0000878526-22-000041:0
700 shares0Bio-Rad A Common StockSEC:0001062993-22-010014:0
270 shares@ US$820.0611.8% of flowBio-Rad A Common StockSEC:0001062993-21-008354:0
270 shares@ US$820.0611.1% of flowBio-Rad A Common StockSEC:0001062993-21-008354
540 shares@ US$524.3015.1% of flowBio-Rad A Common StockSEC:0001062993-21-008242:0
540 shares@ US$524.3014.1% of flowBio-Rad A Common StockSEC:0001062993-21-008242
1,400 shares@ US$309.8421.7% of flowBio-Rad A Common StockSEC:0001062993-21-007078
1,400 shares@ US$309.8423.2% of flowBio-Rad A Common StockSEC:0001062993-21-007078:0
5,214 shares@ US$28.7712.8% of flowCommon Stock, $0.001 par value per shareSEC:0000878526-21-000061
5,214 shares@ US$28.7734.5% of flowCommon Stock, $0.001 par value per shareSEC:0000878526-21-000061:0
2,500 shares@ US$27.465.7% of flowCommon Stock, $0.001 par vale per shareSEC:0000878526-21-000053
2,500 shares@ US$27.4615.5% of flowCommon Stock, $0.001 par vale per shareSEC:0000878526-21-000053:0
19 of 19 declarations
About Daskal Ilan
Daskal Ilan is the Chief Financial Officer and a Board Member of NATUS MEDICAL INC and BIO-RAD LABORATORIES, INC. He oversees the financial operations of these companies, ensuring their financial health and compliance. His expertise in financial management is essential for guiding the strategy and growth of NATUS MEDICAL and BIO-RAD. Daskal plays a key role in financial planning and analysis.
